Skip to main content

Table 4 The distribution of patients presenting a first psychiatric adverse event

From: Emergence of psychiatric adverse events during antipsychotic treatment in AP-naïve children and adolescents

Quarterly follow-up (Q)

All psychiatric AEs (n = 120)

AEs

attributable to AP

(n = 95)

AEs

non attributable to AP

(n = 25)

Q1 (n = 167)

68.3% (82)

70.5% (67)

60% (15)

Q2 (n = 135)

19.2% (23)

17.8% (17)

24% (6)

Q3 (n = 114)

7.5% (9)

7.4% (7)

8% (2)

Q4 (n = 108)

5% (6)

4.2% (4)

8% (2)

  1. Legend : n = number of patients; AE = adverse event; Q = quarter of follow-up; Q1 = 1st to 3rd month; Q2 = 4th to 6th month; Q3 = 7th to 9th month; Q4 = 10th to 12th month of follow-up